Amlodipine Besylate Tablet
Product Images NDC 50090-5354

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 50090-5354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Besylate (Cc27c9a5 Dd2e 4a79 Af00 28f51408362a 01)

Amlodipine Besylate (Cc27c9a5 Dd2e 4a79 Af00 28f51408362a 01)
Chemical structure of Amlodipine Besylate, showing its molecular components including a dihydropyridine ring and a benzene sulfonate group.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Kaplan-Meier analysis graph showing composite clinical outcomes event rates for Amlodipine versus Placebo over 24 months. The plot compares event rates on the y-axis against time in months on the x-axis, with separate curves for Amlodipine and Placebo. Statistical values including P-value, hazard ratio, and 95% confidence interval are noted.*
FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine Besylate and placebo in various patient subgroups, including age, gender, baseline systolic blood pressure, baseline vessel disease, stenosis, and PCI-stent strata. The horizontal axis ranges from 0.0 to 2.0, with markers indicating relative risk favoring Amlodipine or placebo.*
FDA Label Image

Image (1a59ceb2 1cf8 4871 85d6 518fbe49dfef 183 1)

Image (1a59ceb2 1cf8 4871 85d6 518fbe49dfef 183 1)
An instructional or decorative diagram composed of small round shapes arranged in the form of a downward arrow with a circular base. No textual information or pharmaceutical branding is visible.*
FDA Label Image

Label Image (Lbl500905354)

Label Image (Lbl500905354)
Amlodipine Besylate 10 mg oral tablets label from A-S Medication Solutions. The label includes the product number 5902-0, NDC 50090-5354-0, lot number, storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from light, and packaging information indicating a quantity of 30 tablets. The label also notes that each tablet contains an equivalent base amount of Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.